News

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Leading Neuroscientist Joins Critical Path Institute

Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against

Manuscript on Current State of Pharmacometrics in Special Issue of Journal of Clinical Pharmacology Co-authored by C-Path’s Klaus Romero, MS, MD Recently Released

Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, a

Raymond Woosley, MD, PhD, C-Path President/CEO to present keynote address at CDISC North American Exchange November 1-5, 2010 in Baltimore, MD

The CDISC Board of Directors and Dr. Rebecca Kush, President & CEO are pleased to announce three exceptional keynote speakers

Governor Brewer Awards $2.2 Million in Stimulus Dollars Towards Creation of New Biomedical Research Resource in Arizona

Science Foundation Arizona selects Tucson based Critical Path Institute and collaborator, Roche’s Ventana Medical Systems, t

Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases

A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trial

Critical Path Institute’s Predictive Safety Testing Consortium Announces First-Ever Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals an

Critical Path Institute’s Predictive Safety Testing Consortium Announces Special Issue of Nature Biotechnology Dedicated to Newly Qualified Kidney Safety Biomarkers

A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute&#8217

Critical Path Institute President/CEO Receives Award of Excellence

Raymond L. Woosley, MD, PhD, President/CEO of Tucson-based Critical Path Institute (CPI), was recently presented with the prestigi

Global Partners Join Forces to Speed Development of New TB Drug Combinations

FDA applauds effort to take years off development of much needed TB treatments

Critical Path Institute Continues to Expand

Stephen Joel Coons, PhD, Joins as Director of the newly formed Patient-Reported Outcomes Consortium

Previous2728 29...31 Next